Back grey_arrow_rt.gif
 
Archived NATAP Articles from April 2002
 
null.gif
 
 
  1. Patients Can Remain Undetectable for 20 years on HIV Therapy (04/30/02)

    2.  
  2. Cocaine Increased Viral Load & Decreased CD4s in Mice (04/29/02)

    3.  
  3. DIAGNOSTIC VALUE OF LIVER BIOPSY IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION (04/26/02)

    4.  
  4. DIABETES IN HCV - (04/26/02)

    5.  
  5. Bone Mineral Density Loss in HCV - (04/26/02)

    6.  
  6. Report From the 3rd Pharmacology Workshop Reported by Jennifer King for NATAP, PharmD, University of Alabama at Birmingham
    (04/23/02)

    7.  
  7. Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels PDF
    (04/22/02)

    8.  
  8. Hepatitis B Report: adefovir; Pegasys - April 19, 2002

    9.  
  9. Amantadine Triple Therapy: interferon/ribavirin - April 19, 2002

    10.  
  10. Pegasys + Ribavirin: 24 vs 48 weeks; 800 vs 1000/1200 ribavirin - April 18, 2002

    11.  
  11. Neuropsychological Impairment in Patients with Chronic Hepatitis C (04/18/02)

    12.  
  12. NIH STI Study Recruiting: 7 days on & 7 days off HAART (04/11/02)

    13.  
  13. Genotypic Mutations to Predict Kaletra Viral Response (04/4/02)

    14.  
  14. Impact of Hepatitis Coinfection on Health & Survival (04/4/02)

    15.  
  15. Summary Highlights of Retrovirus 2002 (04/4/02)

    16.  
  16. Pathogenesis and Treatment of HIV-Associated Nephropathy - (04/3/02)

    17.  
  17. Bone Density and HIV Infection David Alain Wohl, MD University of North Carolina AIDS Treatment and Research Unit - (04/3/02)

    18.